2025
SJR Q1
JCR Q1 · 4,2
841 matched articles
SCIE
Journal detail
International Journal of Dermatology
- Publisher
- John Wiley and Sons Inc
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0011905913654632
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,875
- Quartile Q1
- H-Index 117
- Cites/doc 1,44
- Docs (3y) 1.648
- Cites (3y) 2.411
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,2
- 5Y JIF 3,8
- JCI 0,88
WoS indexes
- SCIE
Subject classification
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 0,875 | 4,2 | 3,8 | 0,88 | Q2 | 117 |
| 2024 | Q1 | Q1 | 0,822 | 3,3 | 3,2 | 0,72 | Q2 | 111 |
| 2023 | Q1 | Q1 | 0,771 | 3,5 | 3,1 | 0,71 | Q2 | 111 |
| 2022 | Q2 | Q1 | 0,623 | 3,6 | 2,9 | 0,67 | Q2 | 111 |
| 2021 | Q2 | Q2 | 0,66 | 3,2 | 2,8 | 0,69 | Q2 | 111 |
| 2020 | Q2 | Q3 | 0,677 | 2,7 | 2,5 | 0,72 | Q2 | 111 |
| 2019 | Q2 | Q3 | 0,608 | 2,1 | 1,9 | 0,7 | Q2 | 111 |
| 2018 | — | Q3 | — | 1,8 | 1,8 | 0,66 | Q2 | — |
| 2017 | Q2 | Q3 | 0,61 | 1,5 | 1,6 | 0,62 | Q2 | 111 |
| 2016 | Q2 | Q3 | 0,517 | 1,6 | 1,6 | — | — | 111 |
| 2015 | Q2 | Q3 | 0,568 | 1,4 | 1,5 | — | — | 111 |
| 2014 | Q2 | Q3 | 0,596 | 1,3 | 1,4 | — | — | 111 |
| 2013 | Q2 | Q3 | 0,656 | 1,2 | 1,4 | — | — | 111 |
| 2012 | Q2 | Q3 | 0,667 | 1,3 | 1,4 | — | — | 111 |
| 2011 | Q2 | Q3 | 0,639 | 1,1 | 1,4 | — | — | 111 |
| 2010 | Q2 | Q3 | 0,621 | 1,3 | 1,5 | — | — | 111 |
| 2009 | — | Q3 | — | 1,2 | 1,5 | — | — | — |
| 2008 | — | Q3 | — | 1,4 | 1,5 | — | — | — |
| 2007 | — | Q3 | — | 1,1 | 1,3 | — | — | — |
| 2006 | — | Q4 | — | 1 | — | — | — | — |
| 2005 | — | Q4 | — | 0,9 | — | — | — | — |
| 2004 | — | Q3 | — | 0,9 | — | — | — | — |
| 2003 | — | Q4 | — | 0,7 | — | — | — | — |
| 2002 | — | Q3 | — | 0,8 | — | — | — | — |
| 2001 | — | Q3 | — | 0,9 | — | — | — | — |
| 2000 | — | Q3 | — | 0,9 | — | — | — | — |
| 1999 | — | Q3 | — | 0,9 | — | — | — | — |
| 1998 | — | Q3 | — | 0,6 | — | — | — | — |
| 1997 | — | Q3 | — | 0,7 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | DERMATOLOGY | SCIE | Q1 | Q2 | 16/99 |
| 2024 | DERMATOLOGY | SCIE | Q1 | Q2 | 23/96 |
| 2023 | DERMATOLOGY | SCIE | Q1 | Q2 | 20/94 |
| 2022 | DERMATOLOGY | SCIE | Q1 | Q2 | 16/70 |
| 2021 | DERMATOLOGY | SCIE | Q2 | Q2 | 27/69 |
| 2020 | DERMATOLOGY | SCIE | Q3 | Q2 | 38/69 |
| 2019 | DERMATOLOGY | SCIE | Q3 | Q2 | 36/68 |
| 2018 | DERMATOLOGY | SCIE | Q3 | Q2 | 37/66 |
| 2017 | DERMATOLOGY | SCIE | Q3 | Q2 | 39/64 |
| 2016 | DERMATOLOGY | SCIE | Q3 | — | 38/63 |
| 2015 | DERMATOLOGY | SCIE | Q3 | — | 36/61 |
| 2014 | DERMATOLOGY | SCIE | Q3 | — | 38/63 |
| 2013 | DERMATOLOGY | SCIE | Q3 | — | 42/61 |
| 2012 | DERMATOLOGY | SCIE | Q3 | — | 34/59 |
| 2011 | DERMATOLOGY | SCIE | Q3 | — | 39/58 |
| 2010 | DERMATOLOGY | SCIE | Q3 | — | 36/55 |
| 2009 | DERMATOLOGY | SCIE | Q3 | — | 34/48 |
| 2008 | DERMATOLOGY | SCIE | Q3 | — | 29/43 |
| 2007 | DERMATOLOGY | SCIE | Q3 | — | 30/41 |
| 2006 | DERMATOLOGY | SCIE | Q4 | — | 31/39 |
| 2005 | DERMATOLOGY | SCIE | Q4 | — | 30/39 |
| 2004 | DERMATOLOGY | SCIE | Q3 | — | 25/38 |
| 2003 | DERMATOLOGY | SCIE | Q4 | — | 30/38 |
| 2002 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 28/40 |
| 2001 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 24/38 |
| 2000 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 21/36 |
| 1999 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 20/36 |
| 1998 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 24/35 |
| 1997 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 18/32 |